ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681646 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681646; 2) Community: the network communities that were significantly associated with the response to NSC 681646; 3) Molecule: the relationships between components within communities and NSC 681646; 4) MDR: the compounds that were significantly associated with the NSC 681646.

NSC Compound Enrichment Correlation
NSC 663790 Null 0.00415749398947839 0.6117805
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.00423163567577545 0.15442291
NSC 682298 Camptothecin Derivative 0.00423163567577548 0.86011776
NSC 693543 4-Acridinecarboxamide, 9-amino-N-[3-[(2-aminoethyl)amino]propyl]-5-methyl-, trihydrochloride 0.00423163567577548 0.31504934
NSC 736079 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine 0.00423163567577548 0.20042504
NSC 736081 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine 0.00423163567577548 0.03107962
NSC 743244 Null 0.00423163567577548 0.10923712
NSC 743434 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one 0.00423163567577548 0.46325135
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.00423163567577548 0.20143269
NSC 747447 3,19-(4-N,N-dimethylamino)benzylidineandrographolide 0.00423163567577548 -0.0942948
Total:69  Current:8    [First] [Prev] [Next] [Last]